Literature DB >> 2433017

Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases.

S Kakizoe, M Kojiro, T Nakashima.   

Abstract

Among 355 autopsy cases of hepatocellular carcinoma (HCC), 14 cases exhibited sarcomatous appearance (incidence, 3.9%). A clinicopathologic study was performed in these 14 cases, and the immunohistochemical localization of keratin (KRT), vimentin (VMT), albumin (ALB), fibrinogen (FBG) and alpha-fetoprotein (AFP) was also examined using the avidin-biotin complex method. Clinically, the HCCs with sarcomatous appearance were characterized by negative or low serum AFP levels and high incidence of extrahepatic metastasis. Grossly they were of infiltrative, mixed expansive and infiltrative, and pedunculated types. Histologically, the tumor consisted mainly of spindle-shaped cells and partly of multinucleated cells, and showed a sinusoidal growth pattern at the tumor-nontumor boundary. Immunohistochemically, tumor cells in the regions showing sarcomatous appearance were frequently found to be positive to KRT and VMT, whereas the percentage of positivity to ALB, FBG, and AFP were not significantly different from those in ordinary HCC. These results strongly suggest that the lesion showing sarcomatous appearance represents the sarcomatous change of HCC rather than being regarded as the complication of HCC and sarcoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433017     DOI: 10.1002/1097-0142(19870115)59:2<310::aid-cncr2820590224>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  40 in total

1.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Huge subcapsular hematoma caused by intrahepatic sarcomatoid cholangiocarcinoma.

Authors:  Gum O Jung; Dong Eun Park; Gi Jung Youn
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-05-31

3.  Undifferentiated (anaplastic) carcinoma of the pancreas showing sarcomatous change and neoplastic cyst formation.

Authors:  Y Motoo; A Kawashima; H Watanabe; S B Su; T Okai; N Sawabu
Journal:  Int J Pancreatol       Date:  1997-06

4.  Poorly differentiated hepatocellular carcinoma with unusual tubular structures.

Authors:  J Yamaguchi; H Ojima; N Hiraoka; T Hasegawa
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

5.  Carcinosarcoma of the liver with mesenchymal differentiation.

Authors:  Shinichi Sumiyoshi; Masataka Kikuyama; Yuji Matsubayashi; Fujito Kageyama; Yoshihiro Ide; Yoshimasa Kobayashi; Hirotoshi Nakamura
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Primary hepatic choriocarcinoma in a 49-year-old man: report of a case.

Authors:  Ryosuke Sekine; Masanobu Hyodo; Masayuki Kojima; Yoshiyuki Meguro; Akifumi Suzuki; Taku Yokoyama; Alan T Lefor; Norio Hirota
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

7.  Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation.

Authors:  Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Chul-Soo Ahn; Ki-Hun Kim; Kwang-Min Park; Ki-Myung Moon; Deok-Bog Moon; Tae-Yong Ha; Eun-Sil Yu; Ga-Won Choi
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

8.  Biliary carcinosarcoma arising in nonparasitic simple cyst of the liver.

Authors:  T Terada; K Notsumata; Y Nakanuma
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Primary Osteosarcoma of the Liver: Case Report and Literature Review.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

10.  Pelvic skeletal metastasis of hepatocellular carcinoma with sarcomatous change: a case report.

Authors:  Chih-Yu Chen; Yong-Te Hsueh; Tsung-Yu Lan; Wei-Hsin Lin; Karl Wu; Rong-Sen Yang
Journal:  Diagn Pathol       Date:  2010-05-25       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.